These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3318475)

  • 41. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A; Paczka JA; Jiménez-Román J; Hartleben C
    BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
    Schuman JS; Katz GJ; Lewis RA; Henry JC; Mallick S; Wells DT; Sullivan EK; Landry TA; Bergamini MV; Robertson SM
    Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Timolol-pilocarpine combined vs timolol and pilocarpine given separately.
    Geyer O; Rothkoff L; Lazar M
    Am J Ophthalmol; 1990 Jan; 109(1):111. PubMed ID: 2297026
    [No Abstract]   [Full Text] [Related]  

  • 44. [Experiences in a double-blind study with different concentrations of timolol and pilocarpine (author's transl)].
    Merté HJ; Merkle W
    Klin Monbl Augenheilkd; 1980 Oct; 177(4):443-50. PubMed ID: 7019558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of acute closed-angle glaucoma with miotics and timolol.
    Airaksinen PJ; Saari KM; Tiainen TJ; Jaanio EA
    Br J Ophthalmol; 1979 Dec; 63(12):822-5. PubMed ID: 526463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma.
    Konstas AG; Mikropoulos D; Haidich AB; Ntampos KS; Stewart WC
    Br J Ophthalmol; 2009 Apr; 93(4):481-5. PubMed ID: 19019932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Twelve-hour IOP control obtained by a single dose of timolol/pilocarpine combination eye drops.
    Løfors KT; Høvding G; Viksmoen L; Aasved H; Bergaust B; Bulie T
    Acta Ophthalmol (Copenh); 1990 Jun; 68(3):323-6. PubMed ID: 2203218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy.
    Varma R; Hwang LJ; Grunden JW; Bean GW
    Br J Ophthalmol; 2010 Jan; 94(1):80-4. PubMed ID: 19692375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma.
    Konstas AG; Lake S; Maltezos AC; Holmes KT; Stewart WC
    Eye (Lond); 2001 Feb; 15(Pt 1):59-62. PubMed ID: 11318297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the beta-adrenergic receptor-binding agent 'timolol' in the treatment of open-angle glaucoma.
    Strempel I
    Ophthalmologica; 1982; 184(4):198-203. PubMed ID: 6122193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma.
    Konstas AG; Maltezos AC; Gandi S; Hudgins AC; Stewart WC
    Am J Ophthalmol; 1999 Jul; 128(1):15-20. PubMed ID: 10482089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion.
    Zimmerman TJ; Sharir M; Nardin GF; Fuqua M
    Am J Ophthalmol; 1992 Jul; 114(1):1-7. PubMed ID: 1621773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol.
    Konstas AG; Nakos E; Tersis I; Lallos NA; Leech JN; Stewart WC
    Am J Ophthalmol; 2002 Jun; 133(6):753-7. PubMed ID: 12036665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison between pilocarpine and timolol on diurnal pressures in open-angle glaucoma.
    Hass I; Drance SM
    Arch Ophthalmol; 1980 Mar; 98(3):480-1. PubMed ID: 7189114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials.
    Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Suganami H; Araie M;
    JAMA Ophthalmol; 2015 Jul; 133(7):755-61. PubMed ID: 25880207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
    Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.